BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24816743)

  • 1. Whole-exome sequencing identifies a novel genotype-phenotype correlation in the entactin domain of the known deafness gene TECTA.
    Choi BY; Kim J; Chung J; Kim AR; Mun SJ; Kang SI; Lee SH; Kim N; Oh SH
    PLoS One; 2014; 9(5):e97040. PubMed ID: 24816743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of the TECTA c.6183G>T variant identified in a family with autosomal dominant hearing loss: a case report.
    Sansović I; Meašić AM; Odak L; Kero M
    Croat Med J; 2023 Oct; 64(5):329-333. PubMed ID: 37927186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel TECTA mutations identified in stable sensorineural hearing loss and their clinical implications.
    Kim AR; Chang MY; Koo JW; Oh SH; Choi BY
    Audiol Neurootol; 2015; 20(1):17-25. PubMed ID: 25413827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel MYO6 mutation associated with autosomal dominant non-syndromic hearing loss in a Chinese family by whole-exome sequencing.
    Tian T; Lu Y; Yao J; Cao X; Wei Q; Li Q
    Genes Genet Syst; 2018 Dec; 93(5):171-179. PubMed ID: 30175721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of clinical features with mutation of TECTA in a family with autosomal dominant hearing loss.
    Iwasaki S; Harada D; Usami S; Nagura M; Takeshita T; Hoshino T
    Arch Otolaryngol Head Neck Surg; 2002 Aug; 128(8):913-7. PubMed ID: 12162770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exome sequencing identifies a novel frameshift mutation of MYO6 as the cause of autosomal dominant nonsyndromic hearing loss in a Chinese family.
    Cheng J; Zhou X; Lu Y; Chen J; Han B; Zhu Y; Liu L; Choy KW; Han D; Sham PC; Zhang MQ; Zhang X; Yuan H
    Ann Hum Genet; 2014 Nov; 78(6):410-23. PubMed ID: 25227905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DFNA8/12 caused by TECTA mutations is the most identified subtype of nonsyndromic autosomal dominant hearing loss.
    Hildebrand MS; Morín M; Meyer NC; Mayo F; Modamio-Hoybjor S; Mencía A; Olavarrieta L; Morales-Angulo C; Nishimura CJ; Workman H; DeLuca AP; del Castillo I; Taylor KR; Tompkins B; Goodman CW; Schrauwen I; Wesemael MV; Lachlan K; Shearer AE; Braun TA; Huygen PL; Kremer H; Van Camp G; Moreno F; Casavant TL; Smith RJ; Moreno-Pelayo MA
    Hum Mutat; 2011 Jul; 32(7):825-34. PubMed ID: 21520338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rare novel mutation in TECTA causes autosomal dominant nonsyndromic hearing loss in a Mongolian family.
    Bai H; Yang X; Temuribagen ; Guilan ; Suyalatu ; Narisu ; Wu H; Chen Y; Liu Y; Wu Q
    BMC Med Genet; 2014 Mar; 15():34. PubMed ID: 25008054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of TECTA mutation in patients with mid-frequency sensorineural hearing loss.
    Yamamoto N; Mutai H; Namba K; Morita N; Masuda S; Nishi Y; Nakano A; Masuda S; Fujioka M; Kaga K; Ogawa K; Matsunaga T
    Orphanet J Rare Dis; 2017 Sep; 12(1):157. PubMed ID: 28946916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant transcript produced by a splice donor site deletion in the TECTA gene is associated with autosomal dominant deafness in a Brazilian family.
    Lezirovitz K; Batissoco AC; Lima FT; Auricchio MT; Nonose RW; dos Santos SR; Guilherme L; Oiticica J; Mingroni-Netto RC
    Gene; 2012 Dec; 511(2):280-4. PubMed ID: 22995349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three deaf mice: mouse models for TECTA-based human hereditary deafness reveal domain-specific structural phenotypes in the tectorial membrane.
    Legan PK; Goodyear RJ; Morín M; Mencia A; Pollard H; Olavarrieta L; Korchagina J; Modamio-Hoybjor S; Mayo F; Moreno F; Moreno-Pelayo MA; Richardson GP
    Hum Mol Genet; 2014 May; 23(10):2551-68. PubMed ID: 24363064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel TECTA mutation causes ARNSHL.
    Asgharzade S; Tabatabaiefar MA; Modarressi MH; Ghahremani MH; Reiisi S; Tahmasebi P; Abdollahnejad F; Chaleshtori MH
    Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():88-93. PubMed ID: 28012541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cysteine substitution in the zona pellucida domain of alpha-tectorin results in autosomal dominant, postlingual, progressive, mid frequency hearing loss in a Spanish family.
    Moreno-Pelayo MA; del Castillo I; Villamar M; Romero L; Hernández-Calvín FJ; Herraiz C; Barberá R; Navas C; Moreno F
    J Med Genet; 2001 May; 38(5):E13. PubMed ID: 11333869
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel TECTA mutation confirms the recognizable phenotype among autosomal recessive hearing impairment families.
    Alasti F; Sanati MH; Behrouzifard AH; Sadeghi A; de Brouwer AP; Kremer H; Smith RJ; Van Camp G
    Int J Pediatr Otorhinolaryngol; 2008 Feb; 72(2):249-55. PubMed ID: 18022253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exome sequencing identifies a novel CEACAM16 mutation associated with autosomal dominant nonsyndromic hearing loss DFNA4B in a Chinese family.
    Wang H; Wang X; He C; Li H; Qing J; Grati M; Hu Z; Li J; Hu Y; Xia K; Mei L; Wang X; Yu J; Chen H; Jiang L; Liu Y; Men M; Zhang H; Guan L; Xiao J; Zhang J; Liu X; Feng Y
    J Hum Genet; 2015 Mar; 60(3):119-126. PubMed ID: 25589040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exome Sequencing Identifies a Mutation in EYA4 as a Novel Cause of Autosomal Dominant Non-Syndromic Hearing Loss.
    Liu F; Hu J; Xia W; Hao L; Ma J; Ma D; Ma Z
    PLoS One; 2015; 10(5):e0126602. PubMed ID: 25961296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genotype-phenotype correlation with gender-effect for hearing impairment caused by TECTA mutations.
    Pfister M; Thiele H; Van Camp G; Fransen E; Apaydin F; Aydin O; Leistenschneider P; Devoto M; Zenner HP; Blin N; Nürnberg P; Ozkarakas H; Kupka S
    Cell Physiol Biochem; 2004; 14(4-6):369-76. PubMed ID: 15319541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel truncation mutation of EYA4 in moderate degree hearing loss by targeted exome sequencing.
    Choi HS; Kim AR; Kim SH; Choi BY
    Eur Arch Otorhinolaryngol; 2016 May; 273(5):1123-9. PubMed ID: 26015337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prevalence and Clinical Characteristics of
    Yasukawa R; Moteki H; Nishio SY; Ishikawa K; Abe S; Honkura Y; Hyogo M; Mihashi R; Ikezono T; Shintani T; Ogasawara N; Shirai K; Yoshihashi H; Ishino T; Otsuki K; Ito T; Sugahara K; Usami SI
    Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31554319
    [No Abstract]   [Full Text] [Related]  

  • 20. Next-Generation Sequencing Identifies Pathogenic Variants in
    Mei X; Zhou Y; Amjad M; Yang W; Zhu R; Asif M; Hussain HMJ; Yang T; Iqbal F; Hu H
    Neural Plast; 2021; 2021():5528434. PubMed ID: 33976695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.